247 related articles for article (PubMed ID: 38041130)
1. Identification of differentially expressed genes associated with the pathogenesis of gastric cancer by bioinformatics analysis.
Abdolahi F; Shahraki A; Sheervalilou R; Mortazavi SS
BMC Med Genomics; 2023 Dec; 16(1):311. PubMed ID: 38041130
[TBL] [Abstract][Full Text] [Related]
2. Identification of hub genes with prognostic values in gastric cancer by bioinformatics analysis.
Li T; Gao X; Han L; Yu J; Li H
World J Surg Oncol; 2018 Jun; 16(1):114. PubMed ID: 29921304
[TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis of Key Genes and circRNA-miRNA-mRNA Regulatory Network in Gastric Cancer.
Tian Y; Xing Y; Zhang Z; Peng R; Zhang L; Sun Y
Biomed Res Int; 2020; 2020():2862701. PubMed ID: 32908877
[TBL] [Abstract][Full Text] [Related]
4. Bioinformatics Analysis of Hub Genes and Potential Therapeutic Agents Associated with Gastric Cancer.
Zhang S; Xiang X; Liu L; Yang H; Cen D; Tang G
Cancer Manag Res; 2021; 13():8929-8951. PubMed ID: 34876855
[TBL] [Abstract][Full Text] [Related]
5. Integrated bioinformatics analysis reveals novel key biomarkers and potential candidate small molecule drugs in gastric cancer.
Wu Q; Zhang B; Wang Z; Hu X; Sun Y; Xu R; Chen X; Wang Q; Ju F; Ren S; Zhang C; Qi F; Ma Q; Xue Q; Zhou YL
Pathol Res Pract; 2019 May; 215(5):1038-1048. PubMed ID: 30975489
[TBL] [Abstract][Full Text] [Related]
6. Identification of Hub Genes and Potential Pathogenesis in Gastric Cancer Based on Integrated Gene Expression Profile Analysis.
Luu Truong Thanh H; Hoang TM; Hoang Van H
Asian Pac J Cancer Prev; 2024 Mar; 25(3):885-892. PubMed ID: 38546071
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatics analysis identifies COL1A1, THBS2 and SPP1 as potential predictors of patient prognosis and immunotherapy response in gastric cancer.
Wang Y; Zheng K; Chen X; Chen R; Zou Y
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33345281
[TBL] [Abstract][Full Text] [Related]
8. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
Qiu J; Sun M; Wang Y; Chen B
Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
[TBL] [Abstract][Full Text] [Related]
9. [Screening of differentially expressed genes in gastric cancer based on GEO database and function and pathway enrichment analysis].
Liang Y; Lai Y; Yuan Y; Yuan W; Zhang X; Zhang B; Lu Z
Nan Fang Yi Ke Da Xue Xue Bao; 2024 Mar; 44(3):605-616. PubMed ID: 38597453
[TBL] [Abstract][Full Text] [Related]
10. Identification of Potential Biomarkers Associated with Prognosis in Gastric Cancer via Bioinformatics Analysis.
Li D; Yin Y; He M; Wang J
Med Sci Monit; 2021 Feb; 27():e929104. PubMed ID: 33582701
[TBL] [Abstract][Full Text] [Related]
11. Identifying hub genes and miRNAs in Crohn's disease by bioinformatics analysis.
Sun Y; Cai D; Hu W; Fang T
Front Genet; 2022; 13():950136. PubMed ID: 36118873
[No Abstract] [Full Text] [Related]
12. Identification of hub genes and potential molecular mechanisms in gastric cancer by integrated bioinformatics analysis.
Cao L; Chen Y; Zhang M; Xu DQ; Liu Y; Liu T; Liu SX; Wang P
PeerJ; 2018; 6():e5180. PubMed ID: 30002985
[TBL] [Abstract][Full Text] [Related]
13. Unveiling Key Biomarkers and Therapeutic Drugs in Polycystic Ovary Syndrome (PCOS) Through Pathway Enrichment Analysis and Hub Gene-miRNA Networks.
Heidarzadehpilehrood R; Pirhoushiaran M; Binti Osman M; Ling KH; Abdul Hamid H
Iran J Pharm Res; 2023; 22(1):e139985. PubMed ID: 38444712
[TBL] [Abstract][Full Text] [Related]
14. Identification of survival-associated biomarkers based on three datasets by bioinformatics analysis in gastric cancer.
Yin LK; Yuan HY; Liu JJ; Xu XL; Wang W; Bai XY; Wang P
World J Clin Cases; 2023 Jul; 11(20):4763-4787. PubMed ID: 37584004
[TBL] [Abstract][Full Text] [Related]
15. Identification of potential core genes in gastric cancer using bioinformatics analysis.
Shao C; Wang R; Kong D; Gao Q; Xu C
J Gastrointest Oncol; 2021 Oct; 12(5):2109-2122. PubMed ID: 34790378
[TBL] [Abstract][Full Text] [Related]
16. Identification of differentially expressed genes regulated by molecular signature in breast cancer-associated fibroblasts by bioinformatics analysis.
Vastrad B; Vastrad C; Tengli A; Iliger S
Arch Gynecol Obstet; 2018 Jan; 297(1):161-183. PubMed ID: 29063236
[TBL] [Abstract][Full Text] [Related]
17. Bioinformatics Analysis and Identification of Potential Genes Associated with Pathogenesis and Prognosis of Gastric Cancer.
Wang DW; Su F; Yang LJ; Shi LW; Yang TC; Wang HQ; Li XF; Feng MH
Curr Med Sci; 2022 Apr; 42(2):357-372. PubMed ID: 35325407
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of NCAPG, KNL1, miR-148a-3p, miR-193b-3p, and miR-1179 may contribute to the progression of gastric cancer.
Song B; Du J; Song DF; Ren JC; Feng Y
Biol Res; 2018 Nov; 51(1):44. PubMed ID: 30390708
[TBL] [Abstract][Full Text] [Related]
19. Identification of Core Prognosis-Related Candidate Genes in Chinese Gastric Cancer Population Based on Integrated Bioinformatics.
Li M; Wang X; Liu J; Mao X; Li D; Wang Z; Tang Y; Wu S
Biomed Res Int; 2020; 2020():8859826. PubMed ID: 33381592
[TBL] [Abstract][Full Text] [Related]
20. Identifying Diagnostic and Prognostic Biomarkers and Candidate Therapeutic Drugs of Gastric Cancer Based on Transcriptomics and Single-Cell Sequencing.
Zhao X; Wu S; Jing J
Pathol Oncol Res; 2021; 27():1609955. PubMed ID: 34899080
[No Abstract] [Full Text] [Related]
[Next] [New Search]
